144 related articles for article (PubMed ID: 21755434)
1. Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate.
Saleh M; Nikolitch K; Bourcier T; Speeg C; Gaucher D
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):761-4. PubMed ID: 21755434
[No Abstract] [Full Text] [Related]
2. Treatment of primary intraocular lymphoma with intravitreal methotrexate.
Sou R; Ohguro N; Maeda T; Saishin Y; Tano Y
Jpn J Ophthalmol; 2008; 52(3):167-174. PubMed ID: 18661266
[TBL] [Abstract][Full Text] [Related]
3. Spectral-domain Optical Coherence Tomography Patterns in Intraocular Lymphoma.
Keino H; Okada AA; Watanabe T; Echizen N; Inoue M; Takayama N; Nagane M
Ocul Immunol Inflamm; 2016 Jun; 24(3):268-73. PubMed ID: 25760916
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 and interleukin-6 in aqueous humor during treatment of vitreoretinal lymphoma with intravitreally injected methotrexate.
Kawamura H; Yasuda N; Kakinoki M; Sawada T; Sawada O; Ohji M
Ophthalmic Res; 2009; 42(3):172-4. PubMed ID: 19648778
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravitreal methotrexate and aqueous humor cytokine levels in refractory retinal vasculitis in Behcet disease.
Bae JH; Lee SC
Retina; 2012 Jul; 32(7):1395-402. PubMed ID: 22012204
[TBL] [Abstract][Full Text] [Related]
7. Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment.
Kim RY; Park JH; Kim M; Park YG; Cho SG; Park YH
PLoS One; 2021; 16(11):e0260469. PubMed ID: 34813633
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic lymphomatous submaculopathy.
Testi I; Agarwal A; Gupta V;
Indian J Ophthalmol; 2019 Dec; 67(12):2051-2052. PubMed ID: 31755451
[No Abstract] [Full Text] [Related]
9. Serial Detection of
Choi S; Shin S; Lee ST; Lee J; Lee JS; Kim B; Lee CS
Ocul Immunol Inflamm; 2021 Apr; 29(3):485-489. PubMed ID: 32965155
[TBL] [Abstract][Full Text] [Related]
10. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J
BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978
[TBL] [Abstract][Full Text] [Related]
11. Intraocular levels of methotrexate after intravenous administration.
de Smet MD; Stark-Vancs V; Kohler DR; Smith J; Wittes R; Nussenblatt RB
Am J Ophthalmol; 1996 Apr; 121(4):442-4. PubMed ID: 8604740
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal Melphalan for Treatment of Primary Vitreoretinal Lymphoma: A New Indication for an Old Drug.
Shields CL; Sioufi K; Mashayekhi A; Shields JA
JAMA Ophthalmol; 2017 Jul; 135(7):815-818. PubMed ID: 28617918
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience.
Habot-Wilner Z; Frenkel S; Pe'er J
Br J Haematol; 2021 Jul; 194(1):92-100. PubMed ID: 33900619
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate.
Zhao H; Wang X; Mao Y; Peng X
BMC Ophthalmol; 2020 Jan; 20(1):10. PubMed ID: 31906917
[TBL] [Abstract][Full Text] [Related]
15. Diffuse Uveal Melanocytic Proliferation With Primary Vitreoretinal Lymphoma.
Leskov I; Lyon AT; Jampol LM
JAMA Ophthalmol; 2019 Jul; 137(7):834-837. PubMed ID: 31046111
[TBL] [Abstract][Full Text] [Related]
16. Correlation between measurement of IL-10 and IL-6 in paired aqueous humour and vitreous fluid in primary vitreoretinal lymphoma.
Kuiper J; Ten Dam-van Loon N; Domanian A; Schellekens P; Nierkens S; Radstake T; de Boer J
Acta Ophthalmol; 2015 Dec; 93(8):e680-1. PubMed ID: 25833228
[No Abstract] [Full Text] [Related]
17. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
[TBL] [Abstract][Full Text] [Related]
18. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
19. Smudge in my vision.
Nwanyanwu KH; Lim JI
JAMA Ophthalmol; 2013 Dec; 131(12):1637-8. PubMed ID: 24337560
[No Abstract] [Full Text] [Related]
20. Spontaneous regression of intraocular lymphoma.
Kase S; Namba K; Jin XH; Kubota KC; Ishida S
Ophthalmology; 2012 May; 119(5):1083-4. PubMed ID: 22551603
[No Abstract] [Full Text] [Related]
[Next] [New Search]